COVID-19-Associated Coagulopathy: Safety and Efficacy of Prophylactic Anticoagulation Therapy in Hospitalized Adults with COVID-19

[Image: see text] Background: COVID-19-associated coagulopathy increases mortality in patients with COVID-19 infection. The International Society of Thrombosis and Hemostasis (ISTH) has published a guidance document recommending thromboprophylaxis with low-molecular weight heparin (LMWH) for all hos...

Descripción completa

Detalles Bibliográficos
Autores principales: Chambers, Isaac, Dayal, Sanjana, Ten Eyck, Patrick, Eustes, Alicia, Sutamtewagul, Grerk, Rosenstein, Lori, Bailey, Steven R, Lentz, Steven R., Perepu, Usha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
332.Anticoagulation and Antithrombotic Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330284/
http://dx.doi.org/10.1182/blood-2020-141951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330284/
http://dx.doi.org/10.1182/blood-2020-141951

Ejemplares similares